💊FDA PHARMA today 12/19/17 TuesdayBy Tokio X'press offices, FDA, Pharmaceutical 💊FDA PHARMA today 百时美施贵宝公司获得积极的CHMP意见,建议批准Yervoy(伊匹单抗)用于治疗12岁及以上不能切除或转移性黑色素瘤的儿科患者| BMS新闻室 http://www.ono.co.jp/jpnw/PDF/n17_1218.pdf https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-receives-positive-chmp-opinion-recommendi More from tokioX : 💊FDA PHARMA TODAY 💊FDA PHARMA TODAY 💊FDA PHARMA TODAY 💊FDA PHARMA今天 💊FDA PHARMA today 💊Ono与Cyclenium制药公司签署合作协议 💊FDA PHARMA today Post navigation 🚖回想|NHTSA🚖IHS Markit观察和评论今天